Acridine Fluorescent Dye Composition for Clearer Base Sequencing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current next-generation sequencing technologies face increased sequencing error rates due to the partial overlap of emission wavelengths of fluorescent dyes used for base identification, leading to poor distinguishability between different bases.

Innovation Solution

Development of acridine-based fluorescent dyes with a tricyclic rigid planar structure, synthesized using substituted xanthenes, which exhibit a blue shift in emission wavelength to the cyan light region, improving distinguishability and sequencing accuracy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional fluorescent dyes with green and red emission wavelengths are used for base identification, then the sequencing process can be completed, but the emission wavelengths partially overlap leading to poor distinguishability and increased sequencing error rates

Engineering Contradiction:
Improvedistinguishability between basesVSAvoidsequencing error rate
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent changes the emission wavelength parameter of the fluorescent dyes by developing new acridine-based dye structures with cyan emission wavelengths (480-490 nm), which are spectrally distinct from conventional green and red dyes, thereby improving base distinguishability and reducing sequencing errors

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates composite fluorescent dye molecules combining acridine parent nucleus with various substituent groups (carboxyl, hydroxyl, amino, etc.) to achieve optimized optical properties including cyan emission wavelengths and high quantum yields, resulting in superior sequencing performance

Inventive Principle:
Principle #40Composite materials

2Measurement precision

If acridine-based fluorescent dyes with cyan emission wavelengths are developed, then sequencing accuracy is improved, but the dye synthesis requires multiple reaction steps

Engineering Contradiction:
Improvesequencing accuracyVSAvoidsynthesis process complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the dye synthesis into modular reaction steps: first forming the acridine core structure from xanthene precursors, then sequentially adding functional groups (carboxyl, hydroxyl, amino substituents), allowing systematic optimization of each component's contribution to the final optical properties

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent performs preliminary structural planning by selecting xanthene derivatives with specific substituents as starting materials, which are pre-designed to undergo cyclization and form the desired acridine core structure with predetermined functional groups, reducing the need for additional synthesis steps

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The new dyes enhance sequencing accuracy by providing clearer differentiation between bases, reducing error rates and improving sequencing quality.

Implementation Method 1

Acridine (azaanthracene) is a macrocyclic conjugated system with a tricyclic rigid planar structure and strong fluorescence

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentEP4714951A1Fluorescent dye, synthesis therefor and use thereof
Publication Date: 2026.03.25 MGI TECH CO LTD
  • EP4714951A1 patent drawingFigure 1~2A
  • EP4714951A1 patent drawingFigure 2B~3
  • EP4714951A1 patent drawingFigure 4~5

AI summary

The present invention relates to a dye compound and a use thereof as a fluorescent marker, and also relates to a method for preparing the compound, a nucleotide or oligonucleotide labeled by the compound, and a nucleic acid sequencing method.